Indrani L. Franchini

Indrani L. Franchini, J.D., was elected to our Board in July 2024. She is a member of our Audit Committee and our Compliance Committee. From January 2022 to March 2024, Ms. Franchini served as Executive Vice President, Chief Legal Officer and Secretary of Alnylam Pharmaceuticals, Inc.. From June 2017 to July 2021, she served as Executive Vice President and Chief Compliance Officer at Alexion Pharmaceuticals, Inc., where she led a comprehensive transformation of the company’s compliance program. Prior to that, Ms. Franchini held various roles in legal and compliance at Hess Corporation, a Fortune Global 500 leader in oil and gas exploration and production, most recently as Chief Compliance Officer and Assistant Corporate Secretary. Ms. Franchini also spent nearly 10 years at Pfizer in various positions, including supporting the Global Pharmaceutical business. Upon graduating from law school, Ms. Franchini practiced law at Milbank LLP, where she spent six years working in the firm’s New York and Tokyo offices.